results of bone marrow aspiration were compatible with primary thrombocythaemia. The ulcer healed successfully after treatment with oral flucloxacillin and local application of aureomycin cream. He was started on a course of busulphan for his blood disorder.
Seven weeks later there was a pronounced recurrence of the ulceration, now covering the entire outer aspect of the left lower leg. On examination the ulcer had a ragged undermined margin with a bluish tinge, and the edge resembled a collapsed bulla. The appearance was suggestive of pyoderma gangrenosum and biopsy confirmed this diagnosis. Rheumatoid factor was absent, serum protein concentrations and immunoglobulin electrophoresis were normal, and sigmoidoscopy (up to 18 cm) showed no abnormality. He was given prednisolone 40 mg daily, which produced a rapid improvement in the lesion in two weeks and complete healing in five. He now remains in good health without any medication.
Discussion
Pyoderma gangrenosum is most commonly associated with inflammatory bowel disease and rheumatoid arthritis, though it has been reported in association with various forms of leukaemia, ' 2 myelofibrosis,3 and polycythaemia rubra vera. 4 Perry et all reported a more bullous variety of pyoderma gangrenosum associated with leukaemia, which accords with the appearance of the lesion in our patient. The appearance of pyoderma gangrenosum associated with blood disorders may differ from that associated with bowel and joint disease. We can find no confirmed reports of an association with primary thrombocythaemia. of type II diabetes (non-insulin-dependent or maturity-onset diabetes). The implications of the flush were not known until 1978, however, when Leslie and Pyke2 reported that chlorpropamide-alcohol flushing was inherited as an autosomally dominant trait in type II diabetes. This was followed by reports of a lower prevalence ofdiabetic retinopathy,3 large-vessel disease,4 5 peripheral neuropathy,5 and diabetic nephropathy6 in the flushers than in the non-flushers. The prevalence of chlorpropamide-alcohol flushing in type II diabetes has varied considerably at around 30%.-Since the flush reaction seemed to be related to the pathogenesis of angiopathy, studies of its biochemical basis were warranted. We found that flushers had higher blood concentrations of acetaldehyde, the first metabolite of ethanol, than nonflushers during a chlorpropamide-alcohol challenge test.7 We also found higher concentrations of chlorpropamide in flushers than in non-flushers,8 which accords with the fact that chlorpropamide-induced inhibition of aldehyde dehydrogenase leads to a rise in blood acetaldehyde concentrations.9 Barnett et al '0 did not detect this difference in chlorpropamide concentrations between flushers and non-flushers, although they confirmed our finding that acetaldehyde concentrations were increased during the flush. This discrepancy can be explained by the different size of the populations studied (105 subjects in our study8 and 21 in theirs'°). Furthermore, we found a considerable overlap in serum chlorpropamide concentrations, whereas the difference in blood acetaldehyde concentrations was highly significant with a minimal overlap. Obviously other factors might be of importance. This prompted us to study the role of aldehyde dehydrogenase in diabetes.
Acetaldehyde is converted to acetate by aldehyde dehydrogenase, which is distributed in various organs, the highest activity being found in the liver.' Two major isoenzymes have been isolated from mammalian livers; one is mitochondrial with a low Km for aldehydes, the other is cytosolic with a high Km for aldehydes.'2 Inoue et al" isolated aldehyde dehydrogenase from human erythrocytes and found that it shared several characteristics with the cytosolic enzyme. It had a high Km for aldehydes, was strongly inhibited by disulfiram, and had a biphasic nature of kinetics which suggested both high and low affinity sites for acetaldehyde. '4 Patients and methods
Ten type II diabetics with chlorpropamide-alcohol flushing (eight women and two men) and 10 type II diabetics without (five women and five men) were studied. The mean age for men and women was 69 and 62 years respectively, the mean duration after the diagnosis of diabetes six and nine years respectively, and the mean body weight 1170°and 1230o of ideal weight respectively. None of the differences was statistically significant. Five flushers and four non-flushers were treated with diet only whereas five flushers and six non-flushers were treated with glibenclamide or glipizide. All diabetic treatment was stopped for at least 24 hours before any part of the study and the patients were told to refrain from alcohol before the test. The patients were studied with a standardised chlorpropamidealcohol flushing challenge test. Twelve hours after taking 250 mg chlorpropamide the patients were given 8 g of alcohol in fruit juice. The flush reaction was assessed by measuring skin temperature and determining blood acetaldehyde concentrations.2 7 One month later when no chlorpropamide metabolites remained from the challenge test blood samples were collected to study aldehyde dehydrogenase activity.
ALDEHYDE DEHYDROGENASE ACTIVITY
To assess the activity of erythrocyte aldehyde dehydrogenase in flushers and non-flushers we used the method of Inoue et a 15 slightly modified as follows. Blood samples were collected from the patients in the morning in heparinised vacuum tubes, kept at 4°C, and within one hour centrifuged at 1000 x g at 4°C for 10 minutes. Plasma and erythrocytes were mixed in fixed proportions (5: 1) and homogenised by freezing and thawing. Three millilitres of the homogenate was incubated at 37°C with 100 zimol acetaldehyde/l and 1 mmol nicotinamide-adenine dinucleotide (NAD)/l in 5-ml airtight glass vials. Samples were taken at fixed intervals and the reaction stopped by cooling the vials in iced water for 10 minutes followed by deproteination with 0 5 ml 35%O perchloric acid. After centrifugation at 4°C the clear supernatant was assayed for acetaldehyde using head-space gas chromatography.7
Student's t test was used to analyse data from the challenge test and Wilcoxon's test for the data on aldehyde dehydrogenase activity.
Results
During the chlorpropamide-alcohol flushing challenge test the flushers had positive reactions and the non-flushers did not. The mean increase in facial skin temperature was 2 2 -J 0 3C and 0 5 0 1°C for the flushers and non-flushers respectively (p<0 001). The mean increase in blood acetaldehyde concentration 25 minutes after the intake of 8 g of ethanol was 63--16 stmol/l and 1 6X0-2 ,umol/l respectively (p<0-01) for the flushers and non-flushers without any overlap between the two groups (fig 1) . There was no difference in acetaldehyde concentrations between those who were receiving antidiabetic drugs and those who were treated with diet only. The decline of acetaldehyde concentrations in erythrocyte homogenates was exponential with two phases (fige 2). During the first phase no difference between the two groups was seen, whereas the flushers had a slower metabolism of acetaldehyde during the second phase (fig 3) .
Discussion
The enzymatic nature of acetaldehyde metabolism in erythrocytes has been established by Inoue et 
